Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PD-1/L1
Pharma
Merck scores FDA approval for subcutaneous Keytruda
Merck plans to launch Keytruda Qlex soon despite an ongoing patent dispute with Halozyme.
Angus Liu
Sep 19, 2025 4:54pm
Editor's Corner—Summit must submit to Big Pharma, stat
Sep 10, 2025 2:50pm
Roche touts Tecentriq biomarker win in bladder cancer
Aug 18, 2025 4:17pm
Keytruda's novel head and neck cancer nod comes with a limit
Jun 13, 2025 10:50am
FDA limits Keytruda, Opdivo uses in stomach cancer
Jun 9, 2025 10:50am
Fierce Biotech
Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in
Jun 4, 2025 1:00pm
